If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Barry Kreiswirth is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Mycobacterium tuberculosis Medicine & Life Sciences
Methicillin-Resistant Staphylococcus aureus Medicine & Life Sciences
Staphylococcus aureus Medicine & Life Sciences
Klebsiella pneumoniae Medicine & Life Sciences
Carbapenems Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
Genes Medicine & Life Sciences
Plasmids Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2009 2024

Lactams
beta-Lactams
Mycobacterium
Peptidoglycan
Infection
Drug Discovery
Pharmaceutical Preparations
Mycobacterium tuberculosis
Phloroglucinol
Cell Respiration
Colistin
Klebsiella pneumoniae
Mutation
Carbapenems
Clustered Regularly Interspaced Short Palindromic Repeats
Carbapenems
Plasmids
Klebsiella pneumoniae
Klebsiella
Enterobacteriaceae
Pyrazinamide
Tuberculosis
Multidrug-Resistant Tuberculosis
Rifampin
Mycobacterium tuberculosis

Research Output 1982 2020

NTF-RINT, a new method for the epidemiological surveillance of MDR Mycobacterium tuberculosis L2/Beijing strains

Klotoe, B. J., Kurepina, N., Zholdibayeva, E., Panaiotov, S., Kreiswirth, B. N., Anthony, R., Sola, C. & Refrégier, G., Jan 2020, In : Tuberculosis. 120, 101894.

Research output: Contribution to journalArticle

Open Access
Epidemiologic Methods
Multidrug-Resistant Tuberculosis
Isoniazid
Rifampin
Mycobacterium tuberculosis

Activity of imipenem-relebactam and comparator agents against genetically characterized isolates of carbapenem-resistant Enterobacteriaceae

Canver, M. C., Satlin, M. J., Westblade, L. F., Kreiswirth, B. N., Chen, L., Robertson, A., Fauntleroy, K., Spina, M. L., Callan, K. & Jenkins, S. G., Jan 1 2019, In : Antimicrobial agents and chemotherapy. 63, 9, e00672-19.

Research output: Contribution to journalArticle

Carbapenems
Imipenem
Enterobacteriaceae
Klebsiella pneumoniae
Anti-Infective Agents
6 Citations (Scopus)

ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases

Jacobs, M. R., Abdelhamed, A. M., Good, C. E., Rhoads, D. D., Hujer, K. M., Hujer, A. M., Domitrovic, T. N., Rudin, S. D., Richter, S. S., van Duin, D., Kreiswirth, B. N., Greco, C., Fouts, D. E. & Bonomo, R. A., Jan 1 2019, In : Antimicrobial agents and chemotherapy. 63, 1

Research output: Contribution to journalArticle

Stenotrophomonas maltophilia
Siderophores
Acinetobacter baumannii
Carbapenems
Enterobacteriaceae
3 Citations (Scopus)

Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa

Papp-Wallace, K. M., Zeiser, E. T., Becka, S. A., Park, S., Wilson, B. M., Winkler, M. L., D'Souza, R., Singh, I., Sutton, G., Fouts, D. E., Chen, L., Kreiswirth, B. N., Ellis-Grosse, E. J., Drusano, G. L., Perlin, D. S. & Bonomo, R. A., Jul 19 2019, In : The Journal of infectious diseases. 220, 4, p. 666-676 11 p.

Research output: Contribution to journalArticle

Open Access
Fosfomycin
Pseudomonas aeruginosa
Stem Cells
Therapeutics
Mutation Rate
2 Citations (Scopus)

CG258 Klebsiella pneumoniae isolates without β-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City

Eilertson, B., Chen, L., Li, A., Chavda, K. D., Chavda, B. & Kreiswirth, B. N., Jan 1 2019, In : Journal of Antimicrobial Chemotherapy. 74, 1, p. 17-21 5 p.

Research output: Contribution to journalArticle

Lactams
Carbapenems
Klebsiella pneumoniae
Enterobacteriaceae
Capsules